There is a growing body of evidence supporting the therapeutic use of psychedelics, such as LSD and psilocybin (found in magic mushrooms), in treating mental health disorders. Studies have shown promising results in using psychedelics to treat depression, addiction, and the fear of death in people with cancer. These drugs are used in controlled and guided therapeutic settings, where patients are given instructions on how to navigate their experience. The drugs disable the part of the brain where the self talks to itself, allowing for new perspectives and the potential to break free from destructive patterns of thought. Research has shown significant reductions in depression and anxiety in patients, with the FDA approving phase three trials for psychedelic therapy.